R. O. Brady, The enzymatic defect in Gaucher disease, Prog. Clin. Biol. Res, vol.95, pp.309-314, 1982.

V. Barak, M. Acker, and B. Nisman, Cytokines in Gaucher's disease, vol.10, pp.205-210, 1999.

C. Fairley, A. Zimran, and M. Phillips, Phenotypic heterogeneity of N370S homozygotes with type I Gaucher disease: an analysis of 798 patients from the ICGG Gaucher Registry, J. Inherit. Metab. Dis, vol.31, pp.738-744, 2008.

L. Marodi, R. Kaposzta, J. Toth, and A. Laszlo, Impaired microbicidal capacity of mononuclear phagocytes from patients with type I Gaucher disease: partial correction by enzyme replacement therapy, Blood, vol.86, pp.4645-4649, 1995.

B. E. Rosenbloom, N. J. Weinreb, and A. Zimran, Gaucher disease and cancer incidence: a study from the Gaucher Registry, Blood, vol.105, pp.4569-4572, 2005.

F. Y. Choy and T. N. Campbell, Gaucher disease and cancer: concept and controversy, Int. J. Cell Biol, p.150450, 2011.

L. Lacerda, F. A. Arosa, and R. Lacerda, T cell numbers relate to bone involvement in Gaucher disease, Blood Cells Mol. Dis, vol.25, pp.130-138, 1999.

Y. Burstein, V. Zakuth, G. Rechavi, and Z. Spirer, Abnormalities of cellular immunity and natural killer cells in Gaucher's disease, J. Clin. Lab. Immunol, vol.23, pp.149-151, 1987.

Y. Liel, A. Rudich, O. Nagauker-shriker, T. Yermiyahu, and R. Levy, Monocyte dysfunction in patients with Gaucher disease: evidence for interference of glucocerebroside with superoxide generation, Blood, vol.83, pp.2646-2653, 1994.

A. Zimran, D. Elstein, and A. Abrahamov, Significance of abnormal neutrophil chemotaxis in Gaucher's disease, Blood, vol.84, pp.2374-2375, 1994.

I. Micheva, T. Marinakis, and C. Repa, Dendritic cells in patients with type I Gaucher disease are decreased in number but functionally normal, Blood Cells Mol. Dis, vol.36, pp.298-307, 2006.

V. Hornung, S. Rothenfusser, and S. Britsch, Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides, J. Immunol, vol.168, pp.4531-4537, 2002.

T. Kawai and S. Akira, Toll-like receptors and their crosstalk with other innate receptors in infection and immunity, Immunity, vol.34, pp.637-650, 2011.

M. Rimbert, M. Hamidou, and C. Braudeau, Decreased numbers of blood dendritic cells and defective function of regulatory T cells in antineutrophil cytoplasmic antibody-associated vasculitis, PLoS One, vol.6, p.18734, 2011.

M. A. Morgan, A. V. Hoffbrand, M. Laulicht, W. Luck, and S. Knowles, Serum ferritin concentration in Gaucher's disease, Br. Med. J. (Clin. Res. Ed.), vol.286, p.1864, 1983.

P. Stein, H. Yu, D. Jain, and P. K. Mistry, Hyperferritinemia and iron overload in type 1 Gaucher disease, Am. J. Hematol, vol.85, pp.472-476, 2010.

J. Stirnemann, A. Boutten, and C. Vincent, Impact of imiglucerase on the serum glycosylated-ferritin level in Gaucher disease, Blood Cells Mol. Dis, vol.46, pp.34-38, 2010.

A. Mekinian, J. Stirnemann, and N. Belmatoug, Ferritinemia during type 1 Gaucher disease: mechanisms and progression under treatment, Blood Cells Mol. Dis, vol.49, pp.53-57, 2012.

F. Sallusto, D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia, Two subsets of memory T lymphocytes with distinct homing potentials and effector functions, Nature, vol.401, pp.708-712, 1999.

M. K. Pandey, R. Rani, W. Zhang, K. Setchell, and G. A. Grabowski, Immunological cell type characterization and Th1-Th17 cytokine production in a mouse model of Gaucher disease, Mol. Genet. Metab, vol.106, pp.310-322, 2012.

P. K. Mistry, J. Liu, and M. Yang, Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage, Proc. Natl. Acad. Sci. U.S.A, vol.107, pp.19473-19478, 2010.

C. Guiducci, G. Ott, and J. H. Chan, Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation, J. Exp. Med, vol.203, pp.1999-2008, 2006.

D. Vruchte, E. Lloyd-evans, and R. J. Veldman, Accumulation of glycosphingolipids in Niemann-Pick C disease disrupts endosomal transport, J. Biol. Chem, vol.279, pp.26167-26175, 2004.

S. P. Robinson, S. Patterson, and N. English, Human peripheral blood contains two distinct lineages of dendritic cells, Eur. J. Immunol, vol.29, pp.2769-2778, 1999.

J. A. Villadangos and L. Young, Antigen-presentation properties of plasmacytoid dendritic cells, Immunity, vol.29, pp.352-361, 2008.

H. Michelakakis, C. Spanou, and A. Kondyli, Plasma tumor necrosis factor-a (TNF-a) levels in Gaucher disease, Biochim. Biophys. Acta, vol.1317, pp.219-222, 1996.

C. E. Hollak, L. Evers, J. M. Aerts, and M. H. Van-oers, Elevated levels of M-CSF, sCD14 and IL8 in type 1 Gaucher disease, Blood Cells Mol. Dis, vol.23, pp.201-212, 1997.

R. G. Boot, M. Verhoek, and M. De-fost, Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention, Blood, vol.103, pp.33-39, 2004.

H. J. Moller, M. De-fost, H. Aerts, C. Hollak, and S. K. Moestrup, Plasma level of the macrophage-derived soluble CD163 is increased and positively correlates with severity in Gaucher's disease, Eur. J. Haematol, vol.72, pp.135-139, 2004.

P. B. Deegan, M. T. Moran, and I. Mcfarlane, Clinical evaluation of chemokine and enzymatic biomarkers of Gaucher disease, Blood Cells Mol. Dis, vol.35, pp.259-267, 2005.